Is nevro a good company to work for?
Out of 465 Nevro employee reviews, 96% were positive. The Sales team, with 100% positive reviews, reports the best experience at Nevro compared to all other departments at the company. The Customer Support team offered the most constructive feedback, with 8% of that department’s reviews constructive in nature.
How much do nevro reps make?
Nevro Salary FAQs The average salary for a Medical Device Sales Representative is $54,287 per year in United States, which is 11% lower than the average Nevro salary of $61,329 per year for this job.
How many employees does nevro have?
843
Company Description: Nevro Corp. is located in Redwood City, CA, United States and is part of the Medical Equipment and Supplies Manufacturing Industry. Nevro Corp. has 843 total employees across all of its locations and generates $362.05 million in sales (USD)….
| Year | Revenue |
|---|---|
| 2018 | 387.29 |
| 2019 | 390.25 |
| 2020 | 362.05 |
Is nevro public?
(“Nevro”) (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the pricing of concurrent underwritten public offerings of (a) 1,625,000 shares of its common stock at a public offering price of $84.00 per share for gross …
How much do spinal cord stimulator reps make?
Spine Sales Rep Salary
| Annual Salary | Monthly Pay | |
|---|---|---|
| Top Earners | $235,000 | $19,583 |
| 75th Percentile | $121,500 | $10,125 |
| Average | $101,512 | $8,459 |
| 25th Percentile | $42,000 | $3,500 |
Is hf10 covered by insurance?
10 kHz Therapy is covered by nearly all major insurance plans for chronic back and leg pain, including Medicare. Nevro can also provide up-to-date spinal cord stimulation coverage policies for any insurance plan.
How long has nevro been in business?
The company was incorporated in 2006 and is headquartered in Redwood City, California.
What kind of company is nevro?
Nevro is a medical device company and creator of HFX, an innovative, evidence-based treatment for chronic pain of the trunk and/or limbs. The company, headquartered in Redwood City, California has a simple goal of helping more patients suffering from such chronic pain achieve lasting relief.
When did nevro go public?
The company’s shares are expected to begin trading on the New York Stock Exchange on November 6, 2014 under the ticker symbol “NVRO”.